These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 18713049)

  • 21. Pharmacokinetic and pharmacodynamic properties of meropenem.
    Nicolau DP
    Clin Infect Dis; 2008 Sep; 47 Suppl 1():S32-40. PubMed ID: 18713048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update of cefditoren activity tested against community-acquired pathogens associated with infections of the respiratory tract and skin and skin structures, including recent pharmacodynamic considerations.
    Biedenbach DJ; Jones RN
    Diagn Microbiol Infect Dis; 2009 Jun; 64(2):202-12. PubMed ID: 19321284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meropenem.
    Shah D; Narang M
    Indian Pediatr; 2005 May; 42(5):443-50. PubMed ID: 15923690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parenteral carbapenems.
    Shah PM
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():175-80. PubMed ID: 18154543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety profile of meropenem: an updated review of over 6,000 patients treated with meropenem.
    Linden P
    Drug Saf; 2007; 30(8):657-68. PubMed ID: 17696578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring of effectiveness and safety of generic formulation of meropenem for treatment of infections at Siriraj Hospital.
    Angkasekwinai N; Werarak P; Chaiyasoot K; Thamlikitkul V
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S217-24. PubMed ID: 21721450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Doripenem: a new carbapenem in the treatment of nosocomial infection.
    Mandell L
    Clin Infect Dis; 2009 Aug; 49 Suppl 1():S1-3. PubMed ID: 19619016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Nosocomial meningitis with dual agents and treatment with intraventricular gentamicin].
    Oztoprak N; Celebi G; Baruönü F; Kalayci M
    Mikrobiyol Bul; 2008 Jul; 42(3):497-501. PubMed ID: 18822895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of carbapenems in the treatment of severe nosocomial respiratory tract infections.
    Joseph J; Rodvold KA
    Expert Opin Pharmacother; 2008 Mar; 9(4):561-75. PubMed ID: 18312158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formulary review of the carbapenems: comparison of imipenem/cilastatin and meropenem.
    Richerson MA; Ambrose PG; Quintiliani R; Nightingale CH
    Conn Med; 1998 Mar; 62(3):165-9. PubMed ID: 9573653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Doripenem.
    Paterson DL; Depestel DD
    Clin Infect Dis; 2009 Jul; 49(2):291-8. PubMed ID: 19527173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Properties and potential of ertapenem.
    Livermore DM; Sefton AM; Scott GM
    J Antimicrob Chemother; 2003 Sep; 52(3):331-44. PubMed ID: 12917243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic evaluation of doripenem for the treatment of nosocomial pneumonia in the US: discrete event simulation.
    Kongnakorn T; Mwamburi M; Merchant S; Akhras K; Caro JJ; Nathwani D
    Curr Med Res Opin; 2010 Jan; 26(1):17-24. PubMed ID: 19895363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carbapenems in pediatrics.
    Ayalew K; Nambiar S; Yasinskaya Y; Jantausch BA
    Ther Drug Monit; 2003 Oct; 25(5):593-9. PubMed ID: 14508383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbapenem treatment of meningitis.
    Klugman KP; Dagan R
    Scand J Infect Dis Suppl; 1995; 96():45-8. PubMed ID: 7652503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New developments in carbapenems.
    Kattan JN; Villegas MV; Quinn JP
    Clin Microbiol Infect; 2008 Dec; 14(12):1102-11. PubMed ID: 19076841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of meropenem in the treatment of serious infections in children: review of the current literature.
    Arrieta A
    Clin Infect Dis; 1997 Feb; 24 Suppl 2():S207-12. PubMed ID: 9126695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcomes and cost minimization with an alternative dosing regimen for meropenem in a community hospital.
    Patel GW; Duquaine SM; McKinnon PS
    Pharmacotherapy; 2007 Dec; 27(12):1637-43. PubMed ID: 18041884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Review of the guidelines for complicated skin and soft tissue infections and intra-abdominal infections--are they applicable today?
    Caínzos M
    Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():9-18. PubMed ID: 19040462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experience with cefepime versus meropenem as empiric monotherapy for neutropenia and fever in pediatric patients with solid tumors.
    Oguz A; Karadeniz C; Citak EC; Cil V; Eldes N
    Pediatr Hematol Oncol; 2006; 23(3):245-53. PubMed ID: 16517540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.